Himachal Pradesh drug industry is under active scanner of the Centre and the apex drug regulator for violations of medicine safety standards with as many as 71 of India’s 209 firms shortlisted for risk-based inspections housed in the hill state alone.
The Union Government data reveals that out of 209 firms being subjected to inspections by drug regulators following red flags over Indian cough syrups and medicines abroad, 33 per cent (71) are in Himachal Pradesh, followed by Uttarakhand (46), Madhya Pradesh (23), Gujarat (16) and Punjab (seven). Maharashtra, Tamil Nadu and Delhi have five each; Haryana, Karnataka and Telangana four each; West Bengal three; Rajasthan, Sikkim, UP, Puducherry, Kerala, Andhra Pradesh, Bihar, Goa and J&K one each.